Patents by Inventor Alexander Ibach

Alexander Ibach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11391715
    Abstract: Coating compositions are described that include one or more rare metal components, such as rare alkali metal components, as well as diagnostics test elements that incorporate the same. Methods also are described for determining an amount of a dried coating composition in a coat based upon the rare metal components.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 19, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Wolfgang Schick, Alexander Ibach, Yilmaz Isgoeren, Kai Kuellmer
  • Patent number: 10983064
    Abstract: The invention concerns a method and an apparatus for determining the concentration of an analyte in a body fluid, where the following measures are proposed: providing a layered test element (12) including an enzyme-based chemistry layer which is responsive to the analyte by a color change, applying a sample of the body fluid onto the test element (12), detecting by means of a photometric reflectance measuring device (16) a reflectance value of the test element (12), correcting the measured reflectance value by a predetermined offset value attributed to the test element (12), determining a concentration value of the analyte using the offset-corrected reflectance value.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: April 20, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Alexander Ibach, Christian Ringemann, Peter Stephan
  • Publication number: 20190361009
    Abstract: Coating compositions are described that include one or more rare metal components, such as rare alkali metal components, as well as diagnostics test elements that incorporate the same. Methods also are described for determining an amount of a dried coating composition in a coat based upon the rare metal components.
    Type: Application
    Filed: March 29, 2019
    Publication date: November 28, 2019
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Wolfgang Schick, Alexander Ibach, Yilmaz Isgören, Kai Küllmer
  • Patent number: 10371697
    Abstract: The present invention pertains to the field of manufacture of diagnostic test elements. Specifically, the invention relates to a diagnostic test element for determining an analyte comprised in a body fluid sample, said test element comprising at least one test field with at least one detection layer and at least one separation layer, wherein said at least one separation layer comprises dispersed SiO2 in an amount of about 1.0 to 1.6 g/m2. The invention also relates to a coating composition being capable of forming a separation layer on a diagnostic test element of the present invention described above. Moreover, provided is a method for the manufacture of the diagnostic test element as well as the use of the diagnostic test element for determining the amount of an analyte, preferably, glucose, in a sample of a subject.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: August 6, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Alexander Ibach, Yilmaz Isgoeren
  • Patent number: 10274482
    Abstract: Coating compositions are described that include one or more rare metal components, such as rare alkali metal components, as well as diagnostics test elements that incorporate the same. Methods also are described for determining an amount of a dried coating composition in a coat based upon the rare metal components.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: April 30, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Wolfgang Schick, Alexander Ibach, Yilmaz Isgoeren, Kai Kuellmer
  • Publication number: 20180328854
    Abstract: The invention concerns a method and an apparatus for determining the concentration of an analyte in a body fluid, where the following measures are proposed: providing a layered test element (12) including an enzyme-based chemistry layer which is responsive to the analyte by a color change, applying a sample of the body fluid onto the test element (12), detecting by means of a photometric reflectance measuring device (16) a reflectance value of the test element (12), correcting the measured reflectance value by a predetermined offset value attributed to the test element (12), determining a concentration value of the analyte using the offset-corrected reflectance value.
    Type: Application
    Filed: November 21, 2016
    Publication date: November 15, 2018
    Inventors: Alexander Ibach, Christian Ringemann, Peter Stephan
  • Publication number: 20160356765
    Abstract: Coating compositions are described that include one or more rare metal components, such as rare alkali metal components, as well as diagnostics test elements that incorporate the same. Methods also are described for determining an amount of a dried coating composition in a coat based upon the rare metal components.
    Type: Application
    Filed: July 19, 2016
    Publication date: December 8, 2016
    Inventors: Wolfgang Schick, Alexander Ibach, Yilmaz Isgoeren, Kai Kuellmer
  • Publication number: 20160327547
    Abstract: The present invention pertains to the field of manufacture of diagnostic test elements. Specifically, the invention relates to a diagnostic test element for determining an analyte comprised in a body fluid sample, said test element comprising at least one test field with at least one detection layer and at least one separation layer, wherein said at least one separation layer comprises dispersed SiO2 in an amount of about 1.0 to 1.6 g/m2. The invention also relates to a coating composition being capable of forming a separation layer on a diagnostic test element of the present invention described above. Moreover, provided is a method for the manufacture of the diagnostic test element as well as the use of the diagnostic test element for determining the amount of an analyte, preferably, glucose, in a sample of a subject.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 10, 2016
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Alexander Ibach, Yilmaz Isgoeren